TY - JOUR AU - Thanapirom, Kessarin AU - Tsochatzis, Emmanuel A. PY - 2018 TI - Non-alcoholic fatty liver disease (NAFLD) and the quest for effective treatments JF - Hepatobiliary Surgery and Nutrition; Vol 8, No 1 (February 01, 2019): Hepatobiliary Surgery and Nutrition (Special Focus on Antibodies and Liver Transplantation: Part 1) Y2 - 2018 KW - N2 - Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide, affecting 24% of the population, and is impacting on global public health care with a considerable financial burden (1). NAFLD encompasses a wide disease spectrum ranging from simple steatosis to non-alcoholic steatohepatitis (NASH), fibrosis and cirrhosis. UR - https://hbsn.amegroups.org/article/view/22509